U.S. Stem Cell, Inc. 4
4 · U.S. Stem Cell, Inc. · Filed Sep 23, 2016
Insider Transaction Report
Form 4
U.S. Stem Cell, Inc.BHRT.OB
Comella Kristin C
Chief Science Officer
Transactions
- Award
Stock Options (right to buy)
2016-09-19+1,500,000→ 6,697,748 totalExercise: $0.02From: 2016-09-19Exp: 2026-09-19→ Common Stock (1,500,000 underlying) - Award
Stock Options (right to buy)
2016-09-19+5,000,000→ 5,197,748 totalExercise: $0.02Exp: 2026-09-19→ Common Stock (5,000,000 underlying)
Footnotes (1)
- [F1]1,250,000 vest on 09/19/2017, 1,250,000 vest on 09/19/2018, 1,250,000 vest on 09/19/2019, 1,250,000 vest on 09/19/2020